10-18358575-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_201596.3(CACNB2):​c.214-43349A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 141,010 control chromosomes in the GnomAD database, including 34,136 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.70 ( 34136 hom., cov: 23)

Consequence

CACNB2
NM_201596.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.311

Publications

2 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.12).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.729 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.214-43349A>G
intron
N/ANP_963890.2
CACNB2
NM_201590.3
MANE Plus Clinical
c.51+17598A>G
intron
N/ANP_963884.2
CACNB2
NM_201597.3
c.214-43349A>G
intron
N/ANP_963891.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.214-43349A>G
intron
N/AENSP00000320025.8
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.51+17598A>G
intron
N/AENSP00000366546.4
CACNB2
ENST00000352115.10
TSL:1
c.214-43349A>G
intron
N/AENSP00000344474.6

Frequencies

GnomAD3 genomes
AF:
0.698
AC:
98391
AN:
140922
Hom.:
34127
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.645
Gnomad AMI
AF:
0.803
Gnomad AMR
AF:
0.741
Gnomad ASJ
AF:
0.571
Gnomad EAS
AF:
0.353
Gnomad SAS
AF:
0.736
Gnomad FIN
AF:
0.768
Gnomad MID
AF:
0.739
Gnomad NFE
AF:
0.734
Gnomad OTH
AF:
0.684
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.698
AC:
98434
AN:
141010
Hom.:
34136
Cov.:
23
AF XY:
0.699
AC XY:
47573
AN XY:
68072
show subpopulations
African (AFR)
AF:
0.645
AC:
24120
AN:
37398
American (AMR)
AF:
0.741
AC:
10436
AN:
14092
Ashkenazi Jewish (ASJ)
AF:
0.571
AC:
1894
AN:
3316
East Asian (EAS)
AF:
0.353
AC:
1459
AN:
4136
South Asian (SAS)
AF:
0.737
AC:
3258
AN:
4422
European-Finnish (FIN)
AF:
0.768
AC:
6884
AN:
8958
Middle Eastern (MID)
AF:
0.729
AC:
188
AN:
258
European-Non Finnish (NFE)
AF:
0.734
AC:
48188
AN:
65640
Other (OTH)
AF:
0.680
AC:
1294
AN:
1902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.567
Heterozygous variant carriers
0
1185
2371
3556
4742
5927
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
766
1532
2298
3064
3830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.688
Hom.:
4162
Bravo
AF:
0.664
Asia WGS
AF:
0.495
AC:
1643
AN:
3316

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.1
CADD
Benign
2.7
DANN
Benign
0.62
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12356676; hg19: chr10-18647504; API